AXSMHealthcareLarge-Cap

Axsome Therapeutics, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Axsome Therapeutics, Inc. (AXSM), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are AXSM insiders buying or selling?

Axsome Therapeutics, Inc. insiders reported 16 open-market buys ($1.6M) and 42 sells ($194.5M) across 58 Form 4 filings — a net selling position of $193.0M.

Source: SEC EDGAR Form 4

Key Statistics (as of Sep 3, 2026)

Total Form 4 filings
58
SEC EDGAR
Insider filers
9
Insider buys (16)
$1.6M
Insider sells (42)
$194.5M

Insider sentiment

Net selling

Net insider flow of $193.0M in net selling.

Recent AXSM insider transactions

DateInsiderRoleTypeSharesPriceValue
Sep 3, 2026Mark L. JacobsonChief Operating OfficerSale10.0K$208.65$2.1M
Aug 7, 2026Herriot TabuteauChief Executive OfficerSale49.7K$212.19$10.5M
Jul 1, 2026Herriot TabuteauChief Executive OfficerSale49.7K$240.25$11.9M
Jun 12, 2026Roger JeffsDirectorSale572$247.65$141.7K
Jun 11, 2026Susan MahonyDirectorSale600$241.70$145.0K
Jun 11, 2026Mark ColemanDirectorSale643$249.00$160.1K
Jun 9, 2026Herriot TabuteauChief Executive OfficerSale49.7K$241.01$12.0M
Jun 9, 2026Nick PizzieChief Financial OfficerSale33.0K$240.09$7.9M
Jun 2, 2026Mark ColemanDirectorSale17.5K$229.20$4.0M
May 6, 2026Mark L. JacobsonChief Operating OfficerSale4.8K$227.95$1.1M
Apr 24, 2026Ari MaizelChief Commercial OfficerSale7.5K$182.42$1.4M
Feb 28, 2026Mark ColemanDirectorSale25.0K$161.11$4.0M
Feb 28, 2026Mark L. JacobsonChief Operating OfficerSale35.4K$161.88$5.7M
Feb 2, 2026Herriot TabuteauChief Executive OfficerSale32.4K$185.60$6.0M
Jan 24, 2026Nick PizzieChief Financial OfficerSale12.0K$187.92$2.3M
Jan 24, 2026Ari MaizelChief Commercial OfficerSale7.5K$184.44$1.4M
Jan 8, 2026Herriot TabuteauChief Executive OfficerSale139.4K$171.30$23.9M
Jan 3, 2026Mark E SaadDirectorSale37.6K$165.18$6.2M
Dec 5, 2025Herriot TabuteauChief Executive OfficerSale80.0K$145.66$11.6M
Nov 6, 2025Herriot TabuteauChief Executive OfficerSale163.9K$133.07$21.8M
Oct 9, 2025Herriot TabuteauChief Executive OfficerSale45.4K$119.38$5.4M
Sep 22, 2025Mark L. JacobsonChief Operating OfficerSale10.0K$115.96$1.2M
Sep 17, 2025Mark L. JacobsonChief Operating OfficerSale45.8K$114.48$5.2M
Sep 16, 2025Herriot TabuteauChief Executive OfficerSale62.9K$117.08$7.4M
Sep 10, 2025Mark ColemanDirectorPurchase1.6K$127.28$200.5K

Showing the 25 most recent of 58 Form 4 filings for Axsome Therapeutics, Inc..

Most active AXSM insiders

  • Mark Coleman14 filings
  • Mark L. Jacobson10 filings
  • Nick Pizzie9 filings
  • Herriot Tabuteau9 filings
  • Roger Jeffs6 filings

Ask anything about AXSM insider activity

Use Trabud's AI agent to query Axsome Therapeutics, Inc.'s Form 4 history in plain English — "Show me AXSM CEO purchases this year" or compare it against any other ticker.

Open the AI agent

AXSM insider trading FAQ

Are Axsome Therapeutics, Inc. insiders buying or selling?

Across 58 SEC Form 4 filings, Axsome Therapeutics, Inc. (AXSM) insiders reported 16 open-market purchases totaling $1.6M and 42 sales totaling $194.5M. That is a net selling position of $193.0M.

How many insiders trade AXSM stock?

9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Axsome Therapeutics, Inc.. The most recent filing was accepted on Sep 3, 2026.

Where does Trabud get AXSM insider trading data?

All AXSM insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content